Prescription drug · NDA
Viibryd (vilazodone hydrochloride) NDC 0456-1120
Vilazodone hydrochloride 20 mg/1 · Tablet · Oral · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0456-1120-30 | 00456112030 | 30 TABLET in 1 BOTTLE (0456-1120-30)Marketed from Apr 29, 2011 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Viibryd
- Generic name (nonproprietary)
- vilazodone hydrochloride
- Active ingredients
- Vilazodone hydrochloride — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Allergan, Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022567
- Marketing start
- Listing expires
- Identifiers
- Product ID 0456-1120_7502bf82-6281-4d90-8471-1450580c4f3cSPL ID 7502bf82-6281-4d90-8471-1450580c4f3cSPL set ID 4c55ccfb-c4cf-11df-851a-0800200c9a66RxCUI 1086772, 1086776, 1086778, 1086780, 1086784, 1086786, 1086789, 1086790, 1653469, 1653470UNII U8HTX2GK8JUPC 0304561120307, 0304561140305
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400456112030followed by a unit qualifier and the quantityPackage 00456-1120-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
VIIBRYD ® is indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies ( 14 )]. VIIBRYD is indicated for the treatment of major depressive disorder (MDD) in adults ( 1 ).
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 022567
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.